Abstract
The aim of this study was to document the effects of supplementation with a plasma-derived protein C concentrate in adult patients with infectious purpura fulminans. We report the effect of the administration of a human protein C concentrate (Ceprotin, Baxter, Vienna, Austria) in eight adult patients with purpura fulminans. Five patients received the concentrate as level-adjusted continuous infusion (10 U/kg/h, target protein C activity 100%) and three patients received the concentrate as bolus infusions (100 U/kg every 6 h) in addition to standard sepsis therapy. Heparin, fresh-frozen plasma, antithrombin- and fibrinogen concentrates, low-dose rtPA, and platelet transfusions were given when appropriate. Six patients had overt disseminated intravascular coagulation: platelets, 19 g/l; fibrinogen, 60 mg/dl; antithrombin, 47%; prothrombin time, 32%; activated partial thromboplastin time (APTT), 88 s; d-dimer, 66 microg/ml; protein C activity, 29% (medians). Five patients had septic shock, six renal failure and four respiratory failure. Patients received between 5000 and 77,000 U of protein C concentrate over 2.5 days (median); the protein C activity increased to 184% (median) and coagulopathy resolved within 3 days in seven of th...Continue Reading
References
Jun 1, 1992·Chest·R C BoneW J Sibbald
Mar 1, 1992·Chest·F FourrierP Lestavel
Jul 4, 1987·Lancet·J F SinclairD Hallworth
Apr 1, 1995·The Journal of Pediatrics·G E RivardH P Schwarz
Jan 1, 1997·European Journal of Clinical Investigation·M LeviS J van Deventer
Dec 11, 1997·Lancet·O P SmithW Casey
May 20, 1998·Critical Care Medicine·E RintalaV Rasi
May 20, 1998·Critical Care Medicine·W ZenzA Rettenbacher
Sep 12, 1998·Lancet·W KreuzT Beeg
May 13, 1999·Critical Care Medicine·J BriegelK Peter
Aug 19, 1999·The New England Journal of Medicine·M Levi, H Ten Cate
Jan 13, 2000·Seminars in Thrombosis and Hemostasis·C E EttingshausenW Kreuz
Jun 2, 2000·Critical Care Medicine·F LeclercC Fourier
Jun 29, 2000·Intensive Care Medicine·R C ClarkeE E Mayne
Aug 2, 2000·Critical Care Medicine·R M MestersD L Hartman
Aug 2, 2000·Critical Care Medicine·E RintalaP Kotilainen
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Sep 14, 2001·Chest·S B YanG R Bernard
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
May 23, 2003·Intensive Care Medicine·François FourrierOdile Noizet
Jun 10, 2003·Critical Care Medicine·Ester D de KleijnJan A Hazelzet
Nov 20, 2004·Journal of Thrombosis and Haemostasis : JTH·J-F DhainautM Levi
Citations
May 7, 2008·Intensive Care Medicine·Fabio BarattoCarlo Ori
Aug 4, 2009·Intensive Care Medicine·Martina CrivellariArmando D'Angelo
Apr 7, 2010·Wiener medizinische Wochenschrift·Paul Knoebl
Sep 21, 2007·Current Infectious Disease Reports·Herwig Gerlach, Susanne Toussaint
Oct 29, 2014·Medizinische Klinik, Intensivmedizin und Notfallmedizin·F M Brunkhorst, V Patchev
Dec 17, 2008·Clinical and Experimental Dermatology·L NguM Davies
Oct 21, 2016·Intensive Care Medicine·Federico PappalardoAlberto Zangrillo
Dec 17, 2009·Clinical Orthopaedics and Related Research·Savyasachi C ThakkarSimon C Mears
Jul 17, 2009·Acta Paediatrica·Doris FischerAlex Veldman
Jan 31, 2009·Revista española de anestesiología y reanimación·U SalinasL Aguilera
Aug 6, 2013·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sarah C ChristiaansJean Francois Pittet
Nov 28, 2013·Pediatric Blood & Cancer·Francesco De LeonardisNicola Santoro
Jan 30, 2019·Frontiers in Medicine·Lisa A HenschJun Teruya
Sep 13, 2011·The American Journal of Pathology·David FrommholdJohannes Poeschl
Dec 14, 2011·Thrombosis Research·Patrizia Della ValleArmando D'Angelo